Skip to main content

Table 1 Demographic, disease and treatment-related characteristics of participating patients and caregivers (n = 41)

From: A qualitative investigation of the supportive care experiences of people living with pancreatic and oesophagogastric cancer

 

Patient (n = 30)

n(%)

Caregiver (n = 11)

n(%)

Age in years (median (IQR))

64.5 (59 – 73.8)

64.0 (60.5 - 72.5)

Sex

 Male

20 (66.7)

1 (9.1)

 Female

10 (33.3)

10 (90.9)

Cancer type

 Pancreatic

11 (36.7)

7 (63.6)

 Oesophagogastric

19 (63.3)

4 (36.4)

  Oesophageal

13(43.3)

4 (36.4)

  GOJ

2 (6.7)

0 (0)

  Gastric

4(13.3)

0 (0)

Time from diagnosis in months

 4-9 M

10 (33.3)

7 (63.6)

 10-15 M

6 (20.0)

3(27.3)

 16-20 M

4 (13.3)

0 (0)

 21-25 M

6 (20.0)

1 (9.1)

 26-30 M

1 (3.3)

0 (0)

 31-35 M

2 (6.7)

0 (0)

 36 M+

1 (3.3)

0 (0)

Location a

 Major City

18 (60.0)

9 (81.8)

 Inner Regional

7 (23.3)

2 (18.2)

 Outer Regional

5 (16.7)

0 (0)

 Born in a country other than Australia

10 (33.3)

3 (27.3)

 Interpreter required

2 (6.7)

0 (0)

Education level

 Below year 12

13 (43.3)

2 (18.2)

 Year 12

6 (20.0)

2 (18.2)

 Certificate or diploma

7 (23.3)

3 (27.3)

 Undergraduate degree

2 (6.7)

3 (27.3)

 Postgraduate degree

2 (6.7)

1 (9.1)

Current employment status

 Full time

5 (16.7)

1 (9.1)

 Part time

1 (3.3)

3 (27.3)

 Casual

1 (3.3)

1 (9.1)

 No paid work

23 (76.7)

6 (54.5)

Treatment(s) received b

 Pancreatic (n = 11)

  Surgery

8 (72.7)

n/a

  Chemotherapy

11 (100.0)

n/a

  Radiotherapy

2 (18.2)

n/a

 Oesophagogastric (n = 19)

  Surgery

12 (63.2)

n/a

  Chemotherapy

13 (68.4)

n/a

  Radiotherapy

8 (42.1)

n/a

  1. Abbreviations: GOJ Gastro-Oesophageal Junction, IQR Interquartile Range
  2. a Major city, inner and outer regional defined according to the Australian Statistical Geographical Classification Remoteness Area (ASGC-RA) 2016
  3. b %‘s do not equate to 100 as multiple response options were possible. Treatment-level data pertaining to n = 12 patients were derived through interviews as data for these patients were not available through the Upper Gastrointestinal Cancer Registry